News | November 18, 2011

New SCAI Report Provides Recommendations For Treating Multi-Vessel PCI Patients

November 18, 2011 – The first comprehensive report to review timing of treatment for patients with blockages in more than one coronary artery recommends a flexible approach that meets individual patient’s needs. The report was issued today by the Society for Cardiovascular Angiography and Interventions (SCAI) and is published online in Catheterization and Cardiovascular Interventions.

Up to half of all patients with coronary artery disease have blockages in more than more artery. As many as one in five percutaneous coronary intervention (PCI) patients receives treatment in more than one vessel.  SCAI’s new clinical document reviews treatment options for these patients and provides recommendations for treatment of multiple vessels in one stage or in multiple stages.

“When multiple arteries are treated it is usually done in one session, which may not be the safest approach,” said James C. Blankenship, M.D., FSCAI, lead author of the new document. “Yet interventional cardiologists have not had comprehensive recommendations on when it is better to split the treatment of several arteries into two sessions.  Splitting the procedure into separate sessions is less convenient for patients and more costly to insurers.  Thus cardiologists may feel pressured into doing too much in one session.  That can be dangerous for some patients.  With this document, SCAI provides guidance for treating these patients and ensuring every step of the procedure is as safe as possible and appropriate for each patient’s individual health condition.”

The report makes several recommendations for treating multi-vessel coronary artery disease patients, including:

·         Give all PCI patients the best medical therapy, ideally starting before PCI.

·         Treat multiple vessels during diagnostic procedures only if the patient knows the risks and benefits.

·         Start with a strategy for which blockages to treat and which to treat first to get the best outcomes.

·         Change the treatment strategy in mid-procedure if the patient’s condition changes.  

·         Re-evaluate the need for additional treatment at each stage of the procedure.

“Recent research studies have changed our understanding of which patients are best treated with medications, bypass surgery or coronary artery stenting.  We have to translate these scientific studies into guidelines that help doctors treat their patients,” said Blankenship. “This report will help interventional cardiologists provide the best treatment to improve each patient’s health.”

“Society for Cardiovascular Angiography and Interventions (SCAI) Clinical Document: Staging of Multi-Vessel Percutaneous Coronary Interventions” will be published at http://onlinelibrary.wiley.com/doi/10.1002/ccd.23353/abstract

Related Content

NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Overlay Init